Kraken is planning to go public. One of the world’s biggest crypto exchanges has confidentially filed with the US Securities and Exchange Commission for an initial public offering of its common stock, according to the company. Kraken didn’t set a time for when the IPO will happen, but only said it expected it “to occur after the SEC completes its review process, subject to market and other conditions.” Previous reports have predicted that Kraken would go public in the first quarter of 2026. Co-CEO Arju ...

Core Viewpoint - Crypto exchange Kraken has submitted a confidential draft registration statement to the US SEC for a planned IPO, marking a significant step in its growth and the intersection of crypto and traditional finance [1][2][3]. Group 1: IPO Details - Kraken has filed a draft registration statement on Form S-1 with the US SEC for its proposed IPO, although the number of shares and pricing are yet to be determined [2]. - The IPO is expected to proceed once the SEC completes its review, subject to market conditions [2]. Group 2: Market Context - This development follows Circle's public listing and aligns with Ark Invest's prediction regarding favorable conditions for crypto firms under the Trump administration [3][4]. - Ark Invest had previously indicated that pro-crypto policies and SEC reforms could ease regulatory constraints, potentially reopening the IPO window for late-stage digital asset companies like Kraken [4]. Group 3: Financial Aspirations - Kraken aims to raise $500 million at a $15 billion valuation in its planned IPO, with the company having raised $800 million recently [5]. - The move establishes a precedent for crypto firms transitioning to publicly traded companies in the US [5]. Group 4: Competitive Landscape - Once Kraken goes public, its stock, potentially named 'KRAK', would join Coinbase's COIN in the open market [6].

By Arasu Kannagi Basil and Pritam Biswas (Reuters) -Kraken, one of the world's largest cryptocurrency exchanges, said on Wednesday it has confidentially filed for an ​initial public offering in the U.S., as digital asset companies look to tap ‌the new listings market before the 2026 midterm elections. Companies such as stablecoin issuer Circle and crypto exchanges Gemini and Bullish have made ‌strong debuts in the U.S. this year. Kraken's potential listing will fuel competition in a sector where sentime ...

Company Overview - Sudeep Pharma is a technology-driven manufacturer of excipients and specialty ingredients used in the pharmaceutical, food, and nutrition sectors, leveraging in-house technologies to enhance manufacturing efficiency [7][8] - The company has established a global presence in over 100 countries, with significant market penetration in the US, South America, Europe, the Middle East, Africa, and Asia-Pacific [8] - Sudeep Pharma is one of the largest producers of food-grade iron phosphate, with an annual manufacturing capacity of 72,246 metric tonnes as of June 30, 2025 [8] IPO Details - Sudeep Pharma has set a price band of Rs 563–593 per equity share for its initial public offering (IPO), which aims to raise Rs 895 crore, opening for subscription on November 21 and closing on November 25 [2][10] - The IPO consists of a fresh issue of Rs 95 crore and an offer for sale (OFS) of 1,34,90,726 shares by promoters, amounting to Rs 800 crore at the upper price band [10] - The allocation for the IPO includes a maximum of 50% for qualified institutional buyers (QIBs), 15% for non-institutional investors (NIIs), and 35% for retail individual investors [5][10] Use of Proceeds - The company plans to allocate Rs 75.8 crore from the fresh issue for capital expenditure to procure machinery for its production line at the Nandesari Facility 1 in Gujarat, with the remaining funds directed towards general corporate purposes [6][10] Market Sentiment - Sudeep Pharma's shares are currently commanding a 16% grey market premium (GMP), indicating a likely listing price of around Rs 688, which suggests an estimated gain of about Rs 95 per share over the upper issue price of Rs 593 [10] - Recent IPOs have positively influenced investor sentiment, with notable listing gains observed in other companies, contributing to a favorable outlook for Sudeep Pharma's upcoming IPO [10]

Core Viewpoint - Proposals to sell a portion of U.S. mortgage agencies Fannie Mae and Freddie Mac through an initial public offering (IPO) are not seen as viable by Bill Ackman, founder of Pershing Square Capital Management [1] Group 1: Company Insights - Bill Ackman expresses skepticism regarding the feasibility of an IPO for Fannie Mae and Freddie Mac, indicating potential challenges in the execution of such a sale [1]

Billionaire investor Bill Ackman said Tuesday that mortgage titans Fannie Mae (OTCQB:FNMA) and Freddie Mac (OTCQB:FMCC) are still a long way from being ready for an initial public offering. The Trump administration has been considering an IPO of Fannie ( ...

Core Viewpoint - Sudeep Pharma has set a price band of Rs 563–593 for its initial public offering (IPO) of Rs 895 crore, which will open for subscription on November 21 and close on November 25, with an anchor book opening on November 20 [1][7]. Group 1: IPO Details - The IPO consists of a fresh issue of Rs 95 crore and an offer for sale (OFS) of 1,34,90,726 shares by promoter and promoter group shareholders, amounting to Rs 800 crore at the upper end of the price band [1][2]. - At the lower price band of Rs 563, the total offer size is Rs 854.5 crore, while at the upper band, it reaches Rs 895 crore [2][7]. - Investors can bid for a minimum of 25 equity shares, and in multiples of 25 thereafter [2][7]. Group 2: Use of Proceeds - The company plans to allocate Rs 75.8 crore from the fresh issue towards capital expenditure for procuring machinery for its production line at the Nandesari Facility 1 in Gujarat, with the remaining funds directed towards general corporate purposes [2][7]. Group 3: Company Overview - Sudeep Pharma is a technology-driven manufacturer of excipients and specialty ingredients utilized in the pharmaceutical, food, and nutrition sectors, leveraging in-house technologies to enhance innovation and manufacturing efficiency [3][7]. - The company has established a global presence in over 100 countries, with significant market penetration in the US, South America, Europe, the Middle East, Africa, and Asia-Pacific [5][7]. - Sudeep Pharma is one of the largest producers of food-grade iron phosphate, with an annual manufacturing capacity of 72,246 metric tonnes as of June 30, 2025 [5][7]. Group 4: Client Relationships - Over the years, Sudeep Pharma has built relationships with more than 1,100 customers worldwide, including notable clients such as Pfizer Inc, Mankind Pharma, and Merck Group [6][7]. - The IPO will be offered through a book-building route, with allocations of not more than 50% for qualified institutional buyers (QIBs), 15% for non-institutional investors (NIIs), and 35% for retail individual investors [6][8].

More Retail Pvt., the food and grocery chain jointly owned by Amazon.com Inc. and Samara Capital Partners, has picked advisers for an impending initial public offering that could raise about $300 million, according to people familiar with the matter. The Mumbai-based retailer has hired Avendus Capital Pvt. and ICICI Securities Ltd. to begin work on the potential listing, which could value the company at around $2.5 billion, people familiar with the matter said, asking not to be identified as the information ...

Core Insights - York Space Systems experienced a 59% increase in revenue during the first nine months of 2025, as disclosed in its U.S. initial public offering paperwork [1] Company Summary - The company is backed by private equity, indicating strong financial support and potential for growth in the satellite industry [1] - The significant revenue growth suggests a robust demand for satellite services and products, positioning the company favorably in the market [1]

North Carolina, Nov. 14, 2025 (GLOBE NEWSWIRE) -- Off The Hook YS Inc. (“Off The Hook” and the “Company”) (NYSE American: OTH), a premier yacht and boat wholesaler specializing in the buying and selling of yachts and boats, today announced the closing of its initial public offering of 3,750,000 shares of its common stock at a public offering price of $4.00 per share, for gross proceeds of $15,000,000, before deducting underwriting discounts and offering expenses. In addition, Off The Hook has granted the un ...